1. Home
  2. SPFI vs BIOA Comparison

SPFI vs BIOA Comparison

Compare SPFI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo South Plains Financial Inc.

SPFI

South Plains Financial Inc.

HOLD

Current Price

$42.62

Market Cap

794.2M

Sector

Finance

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$24.86

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPFI
BIOA
Founded
1941
2015
Country
United States
United States
Employees
N/A
62
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
794.2M
681.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SPFI
BIOA
Price
$42.62
$24.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$46.00
$51.50
AVG Volume (30 Days)
161.4K
638.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
1.68%
N/A
EPS Growth
17.81
N/A
EPS
0.85
N/A
Revenue
N/A
N/A
Revenue This Year
$22.65
$720.93
Revenue Next Year
$9.40
N/A
P/E Ratio
$51.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.34
$4.11
52 Week High
$45.09
$25.80

Technical Indicators

Market Signals
Indicator
SPFI
BIOA
Relative Strength Index (RSI) 56.01 73.81
Support Level $38.32 $15.42
Resistance Level $44.29 N/A
Average True Range (ATR) 1.15 1.67
MACD 0.18 0.48
Stochastic Oscillator 62.75 89.87

Price Performance

Historical Comparison
SPFI
BIOA

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: